Skip to main content
Log in

PHiD-CV vaccine looks good in Finland

  • Non-clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Bergius S, Torvinen S, Puumalainen T.Clinical and economic impact of a 10-valent pneumococcal-non-typable Haemophilus influenzae-protein D conjugate vaccine on the overall disease burden in Finland. 19th European Congress of Clinical Microbiology and Infectious Diseases: abstr. 89228, 17 May 2009. Available from: URL: http://www.akm.ch/eccmid2009

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

PHiD-CV vaccine looks good in Finland. Pharmacoecon. Outcomes News 581, 5 (2009). https://doi.org/10.2165/00151234-200905810-00013

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200905810-00013

Keywords

Navigation